持田製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2026/05/01 | 3,345 | 3,365 | 3,310 | 3,365 | ±0 | ±0% | 56,900 |
| 2026/04/30 | 3,310 | 3,375 | 3,295 | 3,365 | +15 | +0.4% | 86,500 |
| 2026/04/28 | 3,310 | 3,350 | 3,305 | 3,350 | +5 | +0.1% | 58,200 |
| 2026/04/27 | 3,350 | 3,355 | 3,305 | 3,345 | -45 | -1.3% | 65,500 |
| 2026/04/24 | 3,430 | 3,445 | 3,375 | 3,390 | -40 | -1.2% | 45,200 |
| 2026/04/23 | 3,425 | 3,430 | 3,375 | 3,430 | +25 | +0.7% | 96,400 |
| 2026/04/22 | 3,475 | 3,490 | 3,390 | 3,405 | -105 | -3% | 91,100 |
| 2026/04/21 | 3,590 | 3,590 | 3,490 | 3,510 | -60 | -1.7% | 88,500 |
| 2026/04/20 | 3,625 | 3,625 | 3,540 | 3,570 | -25 | -0.7% | 66,200 |
| 2026/04/17 | 3,610 | 3,635 | 3,560 | 3,595 | -25 | -0.7% | 130,000 |
| 2026/04/16 | 3,675 | 3,675 | 3,610 | 3,620 | -15 | -0.4% | 95,200 |
| 2026/04/15 | 3,550 | 3,650 | 3,535 | 3,635 | +155 | +4.5% | 207,300 |
| 2026/04/14 | 3,550 | 3,555 | 3,475 | 3,480 | -50 | -1.4% | 216,600 |
| 2026/04/13 | 3,430 | 3,540 | 3,400 | 3,530 | +55 | +1.6% | 1,154,800 |
| 2026/04/10 | 3,505 | 3,520 | 3,460 | 3,475 | -25 | -0.7% | 116,000 |
| 2026/04/09 | 3,510 | 3,555 | 3,500 | 3,500 | -35 | -1% | 111,900 |
| 2026/04/08 | 3,460 | 3,535 | 3,440 | 3,535 | +110 | +3.2% | 392,200 |
| 2026/04/07 | 3,415 | 3,450 | 3,410 | 3,425 | -10 | -0.3% | 499,500 |
| 2026/04/06 | 3,495 | 3,565 | 3,415 | 3,435 | -80 | -2.3% | 624,800 |
| 2026/04/03 | 3,580 | 3,605 | 3,500 | 3,515 | -65 | -1.8% | 108,200 |
| 2026/04/02 | 3,605 | 3,660 | 3,565 | 3,580 | -30 | -0.8% | 159,900 |
| 2026/04/01 | 3,580 | 3,645 | 3,525 | 3,610 | +150 | +4.3% | 158,100 |
| 2026/03/31 | 3,500 | 3,545 | 3,430 | 3,460 | -145 | -4% | 268,700 |
| 2026/03/30 | 3,510 | 3,625 | 3,510 | 3,605 | -85 | -2.3% | 34,600 |
| 2026/03/27 | 3,665 | 3,700 | 3,655 | 3,690 | +10 | +0.3% | 40,700 |
| 2026/03/26 | 3,690 | 3,690 | 3,615 | 3,680 | +10 | +0.3% | 34,900 |
| 2026/03/25 | 3,640 | 3,690 | 3,630 | 3,670 | +85 | +2.4% | 27,700 |
| 2026/03/24 | 3,555 | 3,595 | 3,540 | 3,585 | +100 | +2.9% | 16,800 |
| 2026/03/23 | 3,505 | 3,525 | 3,435 | 3,485 | -90 | -2.5% | 35,800 |
| 2026/03/19 | 3,510 | 3,590 | 3,510 | 3,575 | -25 | -0.7% | 66,100 |
| 2026/03/18 | 3,575 | 3,600 | 3,570 | 3,600 | +50 | +1.4% | 19,700 |
| 2026/03/17 | 3,525 | 3,585 | 3,525 | 3,550 | +5 | +0.1% | 11,700 |
| 2026/03/16 | 3,510 | 3,545 | 3,490 | 3,545 | +30 | +0.9% | 17,400 |
| 2026/03/13 | 3,520 | 3,555 | 3,510 | 3,515 | -50 | -1.4% | 32,000 |
| 2026/03/12 | 3,615 | 3,615 | 3,545 | 3,565 | -105 | -2.9% | 26,500 |
| 2026/03/11 | 3,705 | 3,730 | 3,655 | 3,670 | +10 | +0.3% | 23,700 |
| 2026/03/10 | 3,700 | 3,700 | 3,645 | 3,660 | +30 | +0.8% | 21,400 |
| 2026/03/09 | 3,550 | 3,660 | 3,510 | 3,630 | -60 | -1.6% | 35,000 |
| 2026/03/06 | 3,685 | 3,715 | 3,660 | 3,690 | -50 | -1.3% | 23,700 |
| 2026/03/05 | 3,765 | 3,795 | 3,710 | 3,740 | +45 | +1.2% | 30,000 |
| 2026/03/04 | 3,695 | 3,715 | 3,610 | 3,695 | -110 | -2.9% | 44,100 |
| 2026/03/03 | 3,875 | 3,880 | 3,800 | 3,805 | -115 | -2.9% | 41,500 |
| 2026/03/02 | 3,925 | 3,950 | 3,885 | 3,920 | -45 | -1.1% | 33,400 |
| 2026/02/27 | 3,855 | 3,965 | 3,855 | 3,965 | +65 | +1.7% | 46,700 |
| 2026/02/26 | 3,910 | 3,925 | 3,840 | 3,900 | ±0 | ±0% | 43,700 |
| 2026/02/25 | 3,865 | 3,910 | 3,850 | 3,900 | +45 | +1.2% | 45,300 |
| 2026/02/24 | 3,800 | 3,885 | 3,765 | 3,855 | +75 | +2% | 23,500 |
| 2026/02/20 | 3,875 | 3,875 | 3,780 | 3,780 | -100 | -2.6% | 23,100 |
| 2026/02/19 | 3,850 | 3,900 | 3,795 | 3,880 | +30 | +0.8% | 48,100 |
| 2026/02/18 | 3,710 | 3,865 | 3,710 | 3,850 | +180 | +4.9% | 77,300 |
1～
50
件表示中 / 3935件
類似銘柄と比較する
現在ご覧いただいている「持田薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 持田薬 | 336,500円 | +9.8% | +36.4% | 2.38% | 14.20倍 | 0.88倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| サンバイオ | 197,000円 | - | - | 0.00% | - | 11.53倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
| ペプチド | 116,700円 | +72.8% | - | 0.00% | 50.26倍 | 2.93倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
| ゼリア新薬 | 213,200円 | +3.1% | -6.5% | 2.25% | 9.89倍 | 1.03倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| 栄研化 | 306,000円 | +4.1% | -3.1% | 1.90% | 26.76倍 | 2.30倍 |
|
臨床検査薬大手。便潜血検査試薬（ＦＩＴ）はシェア７割。尿検査（ウロ）、遺伝子検査も育成 |
市場注目の銘柄
チャート関連のコラム
